| Patent | Date |
|---|
Method of preparing glucosylceramide synthase inhibitors
Grant 10,954,230 - Siegel , et al. March 23, 2 | 2021-03-23 |
Method Of Preparing Glucosylceramide Synthase Inhibitors
App 20200181137 - SIEGEL; Craig S. ; et al. | 2020-06-11 |
Method of preparing glucosylceramide synthase inhibitors
Grant 10,604,518 - Siegel , et al. | 2020-03-31 |
Method Of Preparing Glucosylceramide Synthase Inhibitors
App 20190031652 - Siegel; Craig S. ; et al. | 2019-01-31 |
Method of preparing glucosylceramide synthase inhibitors
Grant 10,065,949 - Siegel , et al. September 4, 2 | 2018-09-04 |
Method Of Preparing Glucosylceramide Synthase Inhibitors
App 20170334903 - SIEGEL; Craig S. ; et al. | 2017-11-23 |
Method of preparing glucosylceramide synthase inhibitors
Grant 9,682,975 - Siegel , et al. June 20, 2 | 2017-06-20 |
Salt forms of (S)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
Grant 9,518,049 - Siegel , et al. December 13, 2 | 2016-12-13 |
Salt Forms Of (s)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate
App 20160039805 - SIEGEL; Craig S. ; et al. | 2016-02-11 |
Method Of Preparing Glucosylceramide Synthase Inhibitors
App 20160039806 - SIEGEL; Craig S. ; et al. | 2016-02-11 |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
Grant 6,383,814 - Lee , et al. May 7, 2 | 2002-05-07 |
Cationic Amphipile Compositions For Interacelluar Delivery Of Therapeutic Molecules
App 20020013282 - MARSHALL, JOHN ; et al. | 2002-01-31 |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
Grant 6,071,890 - Scheule , et al. June 6, 2 | 2000-06-06 |
Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
Grant 5,948,925 - Keynes , et al. September 7, 1 | 1999-09-07 |
Cationic amphiphile/DNA complexes
Grant 5,948,767 - Scheule , et al. September 7, 1 | 1999-09-07 |
Cationic amphiphiles for cell transfections
Grant 5,942,634 - Siegel , et al. August 24, 1 | 1999-08-24 |
Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
Grant 5,939,401 - Marshall , et al. August 17, 1 | 1999-08-17 |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
Grant 5,935,936 - Fasbender , et al. August 10, 1 | 1999-08-10 |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
Grant 5,925,628 - Lee , et al. July 20, 1 | 1999-07-20 |
Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
Grant 5,912,239 - Siegel , et al. June 15, 1 | 1999-06-15 |
Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
Grant 5,910,487 - Yew , et al. June 8, 1 | 1999-06-08 |
Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules
Grant 5,840,710 - Lee , et al. November 24, 1 | 1998-11-24 |
Cationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic molecules
Grant 5,783,565 - Lee , et al. July 21, 1 | 1998-07-21 |
Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules
Grant 5,767,099 - Harris , et al. June 16, 1 | 1998-06-16 |
Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules
Grant 5,747,471 - Siegel , et al. May 5, 1 | 1998-05-05 |
Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
Grant 5,719,131 - Harris , et al. February 17, 1 | 1998-02-17 |
Child-resistant/non-child-resistant closure
Grant 4,281,771 - Siegel August 4, 1 | 1981-08-04 |
| 